Biotage

Earnings Release • Apr 8, 2010

Press release Biotage AB

Contact: SE-753 18 Uppsala Torben Jörgensen, President and CEO Tel+46 18 56 59 00 Tel: +46 707 49 05 84, torben.jorgensen@biotage.com www.biotage.com

Kungsgatan 76

Uppsala April 8, 2010

Biotage AB (publ) publishes its 2009 Annual Report

Biotage is today publishing its 2009 annual report.

The company generated net sales of 394.1 MSEK (385.3 MSEK).

The operating result amounted to – 10.1 MSEK (27.2 MSEK) and total profit after tax for the year of 13.5 MSEK (299.1 MSEK).

Total profit per share of 0.15 SEK (3.38 SEK).

Financial Goals 2010 and onwards

Following the sale of the Biosystems business area in 2008, Biotage has formulated new long-term financial goals for its operations. An extensive restructuring program was also implemented in 2009 within the remaining operations. In order to achieve the new long-term goals, a continued change process is required as well as a return to a more normal market climate than that experienced in 2009. The market for instruments was particularly weak during the year. Long-term and stable profitability requires a critical mass within each customer segment and having a sufficiently broad product portfolio. This critical mass can be attained through a combination of organic growth and strategic acquisitions. The Company believes that the new long-term goals presented below can be achieved by 2012.

• Organic growth of at least 10 percent
• Increase of the gross margin by 1-2 percentage points per annum, with the goal of achieving a gross margin exceeding 60 percent
• EBIT margin of at least 10 percent

The full report is available at: www.biotage.com

The information in this press release is such that Biotage AB is required to disclose under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. It was released for publication at 8am (CET) on 8 April 2010.

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world's top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com